WCRF. World Cancer Research Fund International: Worldwide. 2012. Accessed 2 Dec 2014.
INCA. Instituto Nacional do Câncer/Estimativa 2014: Incidência de Câncer no Brasil. 2014. http://www.inca.gov.br. Accessed 20 Aug 2014.
Pullar JM, Chisholm A, Jackson C. Dietary information for colorectal cancer survivors: an unmet need. N Z Med J. 2012;125(1356):27–37.
PubMed
Google Scholar
Wang Z, McLoone P, Morrison DS. Diet, exercise, obesity, smoking and alcohol consumption in cancer survivors and the general population: a comparative study of 16282 individuals. Br J Cancer. 2014;27(10):598.
Google Scholar
Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479–507.
Article
CAS
PubMed
Google Scholar
Gu L, Frommel SC, Oakes CC, Simon R, Grupp K, Gerig CY, et al. BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nat Genet. 2014;47(1):22–30.
Article
PubMed
Google Scholar
Molinari C, Casadio V, Foca F, Zingaretti C, Giannini M, Avanzolini A, et al. Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy? J Cell Physiol. 2013;228(12):2343–9.
Article
CAS
PubMed
Google Scholar
Tsanou E, Peschos D, Batistatou A, Charalabopoulos A, Charalabopoulos K. The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res. 2008;28(6A):3815–26.
PubMed
Google Scholar
Sanz-Casla MT, Maestro ML, Vidaurreta M, Maestro C, Arroyo M, Cerdan J. p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value. Dig Dis. 2005;23(2):151–5.
Article
CAS
PubMed
Google Scholar
Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562–73.
Article
CAS
PubMed
Google Scholar
Benderska N, Schneider-Stock R. Transcription control of DAPK. Apoptosis. 2014;19(2):298–305.
Article
CAS
PubMed
Google Scholar
Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-cadherin mediated adhesion system in cancer cells. Cancer. 1996;77(8 Suppl):1605–13.
Article
CAS
PubMed
Google Scholar
Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993;366(6456):704–7.
Article
CAS
PubMed
Google Scholar
De Clerck Y, Szpirer C, Aly MS, Cassiman JJ, Eeckhout Y, Rousseau G. The gene for tissue inhibitor of metalloproteinases-2 is localized on human chromosome arm 17q25. Genomics. 1992;14(3):782–4.
Article
PubMed
Google Scholar
Trzeciak L, Hennig E, Kolodziejski J, Nowacki M, Ostrowski J. Mutations, methylation and expression of CDKN2a/p16 gene in colorectal cancer and normal colonic mucosa. Cancer Lett. 2001;163(1):17–23.
Article
CAS
PubMed
Google Scholar
Furtado Y, Almeida G, Silveira FA, Silva KS, Maldonado P, do Val IC, et al. TIMP-2 gene methylation in cervical precursor and invasive lesions. Exp Mol Pathol. 2015;98(1):119–23.
Article
CAS
PubMed
Google Scholar
Lu F, Du G, Zheng S, Peng L, Chen J. Detection of CDH1 gene methylation of suspension cells in abdominal lavage fluid from colorectal cancer patients and its clinical significance. Zhonghua Wei Chang Wai Ke Za Zhi. 2014;17(11):1133–6.
PubMed
Google Scholar
Bradly DP, Gattuso P, Pool M, Basu S, Liptay M, Bonomi P, et al. CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients. Diagn Mol Pathol Am J Surg Pathol Part B. 2012;21(4):207–13.
Article
CAS
Google Scholar
Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut. 2007;56(1):140–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Grieu F, Watanabe G, et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer. 2006;94(4):593–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zitt M, Muller HM. DNA methylation in colorectal cancer—impact on screening and therapy monitoring modalities? Dis Markers. 2007;23(1–2):51–71.
Article
PubMed Central
CAS
PubMed
Google Scholar
IBGE C. http://censo2010.ibge.gov.br/. 2010. Accessed 24 Jan 2014.
Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci. 1996;93:9821–6.
Article
PubMed Central
CAS
PubMed
Google Scholar
IBGE. Censo Demográfico 2000. http://www.ibge.gov.br/home/estatistica/populacao/tendencia_demografica. 2000. Accessed 19 Aug 2015.
Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers. 2013;5(2):676–713.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wang Q, Jia P, Cheng F, Zhao Z. Heterogeneous DNA methylation contributes to tumorigenesis through inducing the loss of coexpression connectivity in colorectal cancer. Genes Chromosom Cancer. 2015;54(2):110–21.
Article
CAS
PubMed
Google Scholar
Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998;58(23):5489–94.
CAS
PubMed
Google Scholar
Xing X, Cai W, Shi H, Wang Y, Li M, Jiao J, et al. The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis. Br J Cancer. 2013;108(12):2542–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ally MS, Al-Ghnaniem R, Pufulete M. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors. Cancer Epidemiol Biomarkers Prev. 2009;18(3):922–8.
Article
CAS
PubMed
Google Scholar
Kuan JC, Wu CC, Sun CA, Chu CM, Lin FG, Hsu CH, et al. DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study. PLoS One. 2015;10(3):e0123396.
Article
PubMed Central
PubMed
Google Scholar
Li YX, Lu Y, Li CY, Yuan P, Lin SS. Role of CDH1 promoter methylation in colorectal carcinogenesis: a meta-analysis. DNA Cell Biol. 2014;33(7):455–62. doi:10.1089/dna.2013.2291.
Article
PubMed
Google Scholar
Li C, Dong J, Chen MQ, Li WL, Ren JY, Chen SX, et al. Effects of CDH1 gene promoter methylation on expression of E-cadherin and beta-catenin and its clinicopathological significance in colon carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi. 2011;14(7):538–41.
PubMed
Google Scholar
Gozuacik D, Kimchi A. DAPk protein family and cancer. Autophagy. 2006;2(2):74–9.
Article
CAS
PubMed
Google Scholar
Ivanova T, Vinokurova S, Petrenko A, Eshilev E, Solovyova N, Kisseljov F, et al. Frequent hypermethylation of 5′ flanking region of TIMP-2 gene in cervical cancer. Int J Cancer. 2004;108(6):882–6.
Article
CAS
PubMed
Google Scholar
Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999;59(1):67–70.
CAS
PubMed
Google Scholar
Graff JR, Herman JG, Myohanen S, Baylin SB, Vertino PM. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem. 1997;272(35):22322–9.
Article
CAS
PubMed
Google Scholar
Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci. 1996;93:9821–6.
Article
PubMed Central
CAS
PubMed
Google Scholar
Galm O, Suzuki H, Akiyama Y, Esteller M, Brock MV, Osieka R, et al. Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies. Oncogene. 2005;24(30):4799–805.
Article
CAS
PubMed
Google Scholar